Kadant KAI holder files Form 144 to sell 1,435 common shares
Rhea-AI Filing Summary
Kadant Inc. (KAI) had a holder file a Form 144 to potentially sell 1,435 shares of its common stock on the NYSE, with an aggregate market value of $405,019.23.
The planned sale would be executed through Wells Fargo Clearing Services and is targeted around November 25, 2025. The filing notes that 11,778,135 shares of Kadant common stock were outstanding, providing context for the relative size of the proposed sale. The shares were acquired through multiple restricted stock vesting events between June 2022 and September 2023.
Positive
- None.
Negative
- None.
FAQ
What does the Kadant (KAI) Form 144 filing disclose?
The Form 144 filing for Kadant Inc. (KAI) discloses a planned sale of 1,435 shares of Kadant common stock on the NYSE, with an aggregate market value of $405,019.23.
How many Kadant (KAI) shares are planned to be sold and through which broker?
The filing indicates a planned sale of 1,435 common shares of Kadant Inc. through Wells Fargo Clearing Services, to be executed on the NYSE.
When is the approximate sale date for the Kadant (KAI) shares in this Form 144?
The Form 144 lists an approximate sale date of November 25, 2025 for the 1,435 Kadant common shares.
What is the aggregate market value of the Kadant (KAI) shares covered by this Form 144?
The 1,435 Kadant common shares covered by this Form 144 have an aggregate market value of $405,019.23.
How many Kadant (KAI) shares were outstanding according to this Form 144?
The filing reports that 11,778,135 shares of Kadant common stock were outstanding, giving context to the size of the planned 1,435-share sale.
How were the Kadant (KAI) shares in this Form 144 originally acquired?
The shares were acquired through several restricted stock vesting transactions from the issuer between June 1, 2022 and September 30, 2023, in amounts ranging from 60 to 471 shares per vesting event.
What is the purpose of a Form 144 in relation to Kadant (KAI)?
Form 144 is a notice of a proposed sale of restricted or control securities. In this case, it gives notice of a planned sale of Kadant common shares that were previously acquired through restricted stock vesting.